Targeting Ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14 alpha-demethylase

PLoS Neglected Tropical Diseases
Laura-Isobel McCallJames H McKerrow

Abstract

Leishmania protozoan parasites (Trypanosomatidae family) are the causative agents of cutaneous, mucocutaneous and visceral leishmaniasis worldwide. While these diseases are associated with significant morbidity and mortality, there are few adequate treatments available. Sterol 14alpha-demethylase (CYP51) in the parasite sterol biosynthesis pathway has been the focus of considerable interest as a novel drug target in Leishmania. However, its essentiality in Leishmania donovani has yet to be determined. Here, we use a dual biological and pharmacological approach to demonstrate that CYP51 is indispensable in L. donovani. We show via a facilitated knockout approach that chromosomal CYP51 genes can only be knocked out in the presence of episomal complementation and that this episome cannot be lost from the parasite even under negative selection. In addition, we treated wild-type L. donovani and CYP51-deficient strains with 4-aminopyridyl-based inhibitors designed specifically for Trypanosoma cruzi CYP51. While potency was lower than in T. cruzi, these inhibitors had increased efficacy in parasites lacking a CYP51 allele compared to complemented parasites, indicating inhibition of parasite growth via a CYP51-specific mechanism and co...Continue Reading

References

Jul 1, 1991·Molecular and Biochemical Parasitology·A K Tzinia, K P Soteriadou
Nov 1, 1988·Molecular and Biochemical Parasitology·D H BeachG G Holz
Dec 1, 1985·Antimicrobial Agents and Chemotherapy·J D Berman, J V Gallalee
Jun 1, 1985·Molecular and Biochemical Parasitology·L J GoadD H Beach
Feb 1, 1982·The Journal of Infectious Diseases·J D Berman
Dec 1, 1993·The Journal of Antimicrobial Chemotherapy·A Gebre-Hiwot, D Frommel
Jun 1, 1993·Molecular and Biochemical Parasitology·E Medina-Acosta, G A Cross
Dec 31, 1998·Antimicrobial Agents and Chemotherapy·J P GangneuxF Derouin
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
May 14, 2003·Molecular and Biochemical Parasitology·Kelly A Robinson, Stephen M Beverley
Jul 1, 2004·Comparative Immunology, Microbiology and Infectious Diseases·P Desjeux
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Silvia Orenes LorenteIan H Gilbert
Nov 13, 2004·Genome Biology·Jon A Friesen, Victor W Rodwell
Apr 26, 2005·Bioorganic & Medicinal Chemistry·Silvia Orenes LorenteIan H Gilbert
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Hamdan I Al-MohammedPaul A Bates
Nov 1, 2005·Lancet·Henry W MurrayNancy G Saravia
Mar 14, 2007·Clinics in Dermatology·Mark S Bailey, Diana N J Lockwood
Aug 24, 2007·The Lancet Infectious Diseases·Richard ReithingerSimon Brooker
Sep 12, 2007·Antimicrobial Agents and Chemotherapy·Larissa M PodustMichael R Waterman
Feb 5, 2009·PLoS Neglected Tropical Diseases·Chiung-Kuang ChenLarissa M Podust
Aug 15, 2009·Interdisciplinary Perspectives on Infectious Diseases·Wanderley de Souza, Juliany Cola Fernandes Rodrigues
Oct 22, 2009·Nucleic Acids Research·Martin AslettHaiming Wang
Feb 12, 2010·The New England Journal of Medicine·Shyam SundarHenry W Murray
Apr 14, 2010·Antimicrobial Agents and Chemotherapy·Patricia S DoyleLarissa M Podust
May 26, 2010·Molecular Microbiology·Laura-Isobel McCall, Greg Matlashewski
Jun 16, 2010·Biochimica Et Biophysica Acta·Galina I Lepesheva, Michael R Waterman
Feb 2, 2011·Antimicrobial Agents and Chemotherapy·A E Paniz MondolfiE M Sordillo
May 31, 2011·Current Topics in Medicinal Chemistry·Galina I Lepesheva, Michael R Waterman
Jun 14, 2012·Experimental Parasitology·Laura-Isobel McCall, Greg Matlashewski
Jun 14, 2012·PloS One·Jorge AlvarUNKNOWN WHO Leishmaniasis Control Team
Aug 4, 2012·PLoS Neglected Tropical Diseases·Shamila S GunatillekeLarissa M Podust
Jan 10, 2013·PLoS Pathogens·Laura-Isobel McCallGreg Matlashewski
Feb 9, 2013·Parasitology Research·Manjusha M KulkarniBradford S McGwire
Oct 31, 2013·Drugs·Begoña Monge-Maillo, Rogelio López-Vélez

❮ Previous
Next ❯

Citations

Jun 18, 2017·PLoS Neglected Tropical Diseases·Roy MwenechanyaMichael P Barrett
Jun 21, 2017·Molecular and Biochemical Parasitology·Samuel M DuncanJeremy C Mottram
May 3, 2018·Expert Opinion on Therapeutic Targets·Shyam Sundar, Bhawana Singh
Feb 20, 2019·International Journal of Molecular Sciences·Ronna Delgado-AltamiranoAlejandra Rojas-Molina
Jul 13, 2019·Current Medicinal Chemistry·Marcus Tullius ScottiLuciana Scotti
Feb 1, 2020·Current Drug Targets·Pone Kamdem BonifaceFerreira Igne Elizabeth
Jul 5, 2018·Apoptosis : an International Journal on Programmed Cell Death·Bhanu Priya Awasthi, Kalyan Mitra
Jan 23, 2019·Frontiers in Cellular and Infection Microbiology·Juan Felipe Osorio-Méndez, Ana María Cevallos
Mar 23, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Masoud KeighobadiReza Valadan
Nov 18, 2016·PLoS Neglected Tropical Diseases·Frédéric-Antoine DauchyDerrick R Robinson
Feb 20, 2019·International Journal of Molecular Sciences·Shuobing FanTing Shi
Dec 19, 2018·Pharmaceutical Research·Helen W HernandezSean Ekins
Jul 19, 2019·Frontiers in Cellular and Infection Microbiology·Karina M RebelloClaudia M d'Avila-Levy
Sep 13, 2019·European Journal of Medicinal Chemistry·Susana Santos Braga
Sep 7, 2020·Experimental Parasitology·Durgesh Manohar PitaleChandrima Shaha
Jan 23, 2021·RSC Medicinal Chemistry·Humera AhmedRoderick A M Williams
Feb 28, 2021·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·S BahramiE Bemani
Apr 6, 2021·Journal of Cellular Biochemistry·Shams TabrezAbdur Rub
Jul 3, 2021·Biomedicines·Zemfira N KaramyshevaKai Zhang
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Juliana Figueiredo PeixotoCarlos Roberto Alves
Jul 27, 2021·Bioorganic & Medicinal Chemistry Letters·Fernanda S AlmeidaRicardo Olímpio de Moura
Jul 27, 2021·Current Opinion in Microbiology·Kai Zhang
Aug 28, 2019·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Bruno MendesDanilo C Miguel

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
flow cytometry
electrophoresis

Software Mentioned

FloJo X
Image J
IN CELL developer

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.